Ambrx Biopharma Inc. (AMAM)
Company Info
ISIN | US02290A1025 |
---|---|
CUSIP | 02290A102 |
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | $1.77B |
---|---|
EPS (TTM) | $0.42 |
PE Ratio | 66.67 |
Total Revenue (TTM) | $53.00K |
Gross Profit (TTM) | $53.00K |
EBITDA (TTM) | -$25.11M |
Year Range | $6.55 - $28.15 |
Target Price | $28.67 |
Short % | 3.28% |
Short Ratio | 1.21 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: AMAM vs. KAMN, AMAM vs. VTSAX, AMAM vs. PFE, AMAM vs. SMCI, AMAM vs. PLTR
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Ambrx Biopharma Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Period | Return | Benchmark |
---|---|---|
Year-To-Date | N/A | 16.48% |
1 month | N/A | 1.67% |
6 months | N/A | 14.21% |
1 year | N/A | 21.98% |
5 years (annualized) | N/A | 13.13% |
10 years (annualized) | N/A | 10.91% |
Monthly Returns
The table below presents the monthly returns of AMAM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 95.22% | 0.50% | 96.63% | ||||||||||
2023 | -16.74% | 240.21% | 38.72% | 8.02% | 53.19% | 11.52% | -7.35% | -7.41% | -18.56% | -9.48% | 10.85% | 23.40% | 527.31% |
2022 | -46.40% | -7.23% | -8.24% | -7.52% | 3.15% | -32.57% | 4.91% | -40.65% | -34.55% | -9.54% | -49.85% | 363.27% | -74.86% |
2021 | 14.96% | -0.26% | -8.90% | -24.20% | -6.67% | -25.79% | -3.42% | -47.04% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of AMAM is 94, placing it in the top 6% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Ambrx Biopharma Inc. (AMAM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Ambrx Biopharma Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ambrx Biopharma Inc. was 98.18%, occurring on Dec 8, 2022. Recovery took 270 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-98.18% | Jul 14, 2021 | 356 | Dec 8, 2022 | 270 | Jan 8, 2024 | 626 |
-6.45% | Jun 21, 2021 | 2 | Jun 22, 2021 | 3 | Jun 25, 2021 | 5 |
-4.08% | Jul 1, 2021 | 1 | Jul 1, 2021 | 2 | Jul 6, 2021 | 3 |
-2.47% | Jul 9, 2021 | 2 | Jul 12, 2021 | 1 | Jul 13, 2021 | 3 |
-2.27% | Jun 28, 2021 | 1 | Jun 28, 2021 | 1 | Jun 29, 2021 | 2 |
Volatility
Volatility Chart
The current Ambrx Biopharma Inc. volatility is 0.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
P/E Ratio
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Ambrx Biopharma Inc..
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |